We are live on ! Find out more
VIVS

VivoSim Labs
VIVS

31 hedge funds and large institutions have $912K invested in VivoSim Labs in 2024 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.1% less ownership

Funds ownership: 0.83% → 0.73% (-0.1%)

6% less funds holding

Funds holding: 33 → 31 (-2)

7% less capital invested

Capital invested by funds: $979K → $912K (-$67.8K)

11% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 9

33% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 6

Holders
31
Holders Change
-2
Holders Change %
-6.06%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
4
Reduced
6
Closed
9
Calls
$17K
Puts
–
Net Calls
+$17K
Net Calls Change
+$17K

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$48.1K
2
XT
XTX Topco
Cayman Islands
+$23.5K
3
UBS Group
UBS Group
Switzerland
+$13K
4
TSS
Two Sigma Securities
New York
+$12.2K
5
TRCT
Tower Research Capital (TRC)
New York
+$2.43K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$44.8K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$26.7K
3
CCM
Connective Capital Management
California
-$15.4K
4
BlackRock
BlackRock
New York
-$5.5K
5
Renaissance Technologies
Renaissance Technologies
New York
-$3.84K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$364K – – –
BlackRock
2
BlackRock
New York
$146K -$5.5K -442 -4%
Renaissance Technologies
3
Renaissance Technologies
New York
$101K -$3.84K -308 -4%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$77.2K +$785 +63 +1%
Citadel Advisors
5
Citadel Advisors
Florida
$47.8K +$48.1K +3,865 New
Morgan Stanley
6
Morgan Stanley
New York
$43.4K -$44.8K -3,596 -51%
State Street
7
State Street
Massachusetts
$28.7K – – –
XT
8
XTX Topco
Cayman Islands
$23.3K +$23.5K +1,886 New
RJA
9
Raymond James & Associates
Florida
$20.4K – – –
UBS Group
10
UBS Group
Switzerland
$15.6K +$13K +1,042 +480%
Northern Trust
11
Northern Trust
Illinois
$15.1K – – –
TSS
12
Two Sigma Securities
New York
$12.1K +$12.2K +979 New
TRCT
13
Tower Research Capital (TRC)
New York
$7.74K +$2.43K +195 +45%
Russell Investments Group
14
Russell Investments Group
United Kingdom
$2.59K – – –
Osaic Holdings
15
Osaic Holdings
Arizona
$2.02K -$162 -13 -7%
AFG
16
Albion Financial Group
Utah
$1.97K – – –
QPBE
17
Quintet Private Bank (Europe)
Luxembourg
$512 +$448 +36 New
Wells Fargo
18
Wells Fargo
California
$433 +$12 +1 +3%
CAM
19
Creekmur Asset Management
Illinois
$422 +$423 +34 New
Bank of America
20
Bank of America
North Carolina
$318 -$87 -7 -21%
KFS
21
Kelly Financial Services
Massachusetts
$173 – – –
Toronto Dominion Bank
22
Toronto Dominion Bank
Ontario, Canada
$78 – – –
JP Morgan Chase
23
JP Morgan Chase
New York
$65 – – –
Fidelity Investments
24
Fidelity Investments
Massachusetts
$52 +$50 +4 New
AWM
25
Avior Wealth Management
Nebraska
$33 +$37 +3 New
1
2

VIVS Hedge Fund Activity: Q1 2024 in Review

31 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in VivoSim Labs (VIVS) for Q1 2024, worth a combined $912K — down 6.9% from $979K a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of VIVS and 8 opened new positions — a net loss of 1 holder — while 6 trimmed existing stakes and 4 added.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $48.1K. The largest seller was Morgan Stanley, cutting an estimated $44.8K.

  • 31 institutional investors held VivoSim Labs (VIVS) as of Q1 2024, down from 33 in Q4 2023.
  • Funds reported $912K of VivoSim Labs stock for Q1 2024, down 6.9% quarter-over-quarter.
  • 8 funds opened new VivoSim Labs positions in Q1 2024 and 9 closed out, a net change of -1 holder.
  • The largest VivoSim Labs buyer in Q1 2024 was Citadel Advisors, an estimated $48.1K added.
  • The largest VivoSim Labs seller in Q1 2024 was Morgan Stanley, an estimated $44.8K sold.

Based on aggregated 13F filings for Q1 2024.